Clinical Trials Directory

Trials / Unknown

UnknownNCT01501968

Efficacy of Ascorbic Acid for Prevention of Colistin-Associated Nephrotoxicity

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
54 (estimated)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Ascorbic acid (Vitamin C) could protect renal toxicity from colistin.

Detailed description

Renal toxicity due to colistin therapy is common. Ascorbic acid (vitamin C) has been shown to prevent colistin associated renal toxicity in animals. This study is conducted to determine if acorbic acid can prevent Colistin-Associated Nephrotoxicity.

Conditions

Interventions

TypeNameDescription
DRUGColistinColistimethate sodium 2.5-5mg/kg iv per day
DRUGColistin + Ascorbic acidColistimethate sodium 2.5-5mg/kg iv per day and ascorbic acid 2 grams iv q 12 hours

Timeline

Start date
2012-01-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2011-12-30
Last updated
2011-12-30

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01501968. Inclusion in this directory is not an endorsement.

Efficacy of Ascorbic Acid for Prevention of Colistin-Associated Nephrotoxicity (NCT01501968) · Clinical Trials Directory